% | $
Quotes you view appear here for quick access.

Emisphere Technologies, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • ivoroshea ivoroshea Oct 12, 2009 4:49 PM Flag

    1st Primary Endpoint Measurement Completed

    I agree with your analysis here.

    A key date for me to understand these trials' progress is 9 December when Novartis is giving a general pipeline update to analysts (albeit with a special focus on oncology).

    As diverse & impressive as Novartis' pipeline is, I fail to see how they won't spend time discussing a compound with potential for disease modification in osteoarthritis - i.e. not just symptom relief. The fact the first PIII is due to report in Q3 2010 should also attract attention on the day.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.480.00(0.00%)Apr 24 2:47 PMEDT